Christophe T.
- Country
- France
- Department
- Medical oncology
Research Overview
- Sotorasib and Combination Therapy Versus Standard Chemotherapy in Treatment-Naïve Patients with KRAS p.G12C-Mutated Metastatic Colorectal Cancer
- Efficacy and Safety of PF-08634404 and Combination Therapy Versus Bevacizumab and Combination Therapy in Treatment-Naïve Participants With Metastatic Colorectal Cancer
- Evaluation of Molecular Targeted Maintenance Therapy with Binimetinib, Futibatinib, and Drug Combination in Advanced Biliary Cancer: A Phase 3 Randomized Trial
Data & Insights
Has run more than one trial at 280 of 579 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating various gastrointestinal cancers, with particular focus on advanced and metastatic conditions. Their research encompasses colorectal cancer, biliary tract cancer, and gastroesophageal adenocarcinoma.
- Metastatic Colorectal Cancer Management
- Advanced Biliary Tract Cancer Treatment
- Gastroesophageal Cancer Therapies
Urological Oncology
Focuses on treating complex urological malignancies including bladder cancer, renal cell carcinoma, and prostate cancer. Their expertise extends to both muscle-invasive and non-muscle invasive conditions.
- Bladder Cancer Immunotherapy
- Metastatic Renal Cell Carcinoma
- Advanced Prostate Cancer Treatment
Breast Cancer
Specializes in treating hormone receptor-positive and HER2-negative breast cancer. Their work focuses on advanced and metastatic disease states requiring targeted therapeutic approaches.
- Advanced Breast Cancer Treatment
- Hormone Receptor-Positive Disease Management
- Metastatic Breast Cancer Therapies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.